Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Europe's STOXX 600 marks third month of gains on earnings, recovery hopes

Fri, 30th Apr 2021 09:54

* AstraZeneca boosts UK's FTSE 100

* Barclays tumbles despite profit beat

* STOXX 600 chalks up 1.8% rise in April

* European economy dips into second technical recession in
Q1
(Updates to market close)

By Sruthi Shankar and Ambar Warrick

April 30 (Reuters) - European stocks ended lower on Friday
after dismal GDP data, but marked a third straight month of
gains on strong corporate earnings and optimism about an
economic recovery from the COVID-19 pandemic.

The pan-regional STOXX 600 index fell 0.3%,
hovering below its all-time high, and ending the month 1.8%
higher.

Data showed the euro zone economy dipped into a second
technical recession after a smaller than expected contraction in
the first quarter, but is now set for recovery as pandemic curbs
are lifted amid accelerating vaccination campaigns.

The German economy contracted by a greater-than-expected
1.7%, hit by renewed lockdowns, while the French economy grew
more than expected.

But strong earnings showed companies in the euro zone were
well on their way to recover from the impact of the pandemic.

AstraZeneca jumped 4.3% as the British drugmaker
posted better-than-expected results and forecast second half
growth.

Swedish Match rose 0.7% after the tobacco group
reported a much higher first-quarter operating profit than
expected, helped by growth in its Smokefree product segment. UK
peers British American Tobacco and Imperial Brands
rose more than 2% each.

Broadly, European earnings have come in much stronger than
expected, with a higher than usual 71% of companies beating
profit expectations in the first quarter, according to Refinitiv
IBES data. A third of STOXX 600 companies have published results
so far.

"Expectations are high, companies are beating even these
elevated expectations, and yet the market is responding with
caution," Lewis Grant, portfolio manager at Federated Hermes,
wrote in a note.

"At current valuations, and with much pandemic related
uncertainty remaining, many investors are more concerned about
downside than upside."

Strong earnings from British firms helped the European
retailers sector outpace its peers in April with a 6.7%
bounce, while automobile stocks lagged as a global
semiconductor shortage hurt production.

Banking stocks came under pressure on Friday as euro
zone bond yields eased from their highest level since January
2020. But the sector raced past its peers this week with a near
6% gain, driven by a swathe of strong earnings.

Barclays tumbled 7% despite reporting a quarterly
profit that more than doubled, while France's BNP Paribas
slipped 0.8% on higher costs.

Spain's Banco Sabadell jumped 8.7% to the top of
the STOXX 600 after its quarterly profit beat market
expectations, helped by strength in its British unit TSB.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Mark Potter)

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.